Enlivex Therapeutics Ltd.

ENLV

$197M

Micro Cap

NASDAQBiotechnology🇺🇸North America

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Mar 15, 2026

12w

Drug Pipeline

Drug Name	Phase	Indication	Designations
Allocetra	Phase 2	Osteoarthritis, Knee	-
Allocetra-OTS	Phase 2	Sepsis	-

Catalyst Timeline

1 upcoming, 0 past

Phase 2Next

Mar 15, 2026Allocetra

Primary completion for Allocetra trial (NCT06233474) in Osteoarthritis, Knee

Regulatory Approvals

ENLV News